Index -
P/E 39.99
EPS (ttm) 9.82
Insider Own 18.29%
Shs Outstand 30.68M
Perf Week -0.85%
Market Cap 12.16B
Forward P/E 29.88
EPS next Y 13.14
Insider Trans -30.08%
Shs Float 25.32M
Perf Month 0.87%
Income 312.32M
PEG 2.23
EPS next Q 2.53
Inst Own 80.69%
Short Float 3.89%
Perf Quarter 32.79%
Sales 1.96B
P/S 6.20
EPS this Y 26.02%
Inst Trans -1.64%
Short Ratio 3.45
Perf Half Y 56.02%
Book/sh 21.72
P/B 18.07
EPS next Y 17.39%
ROA 19.57%
Short Interest 0.98M
Perf Year 91.05%
Cash/sh 13.14
P/C 29.88
EPS next 5Y 17.91%
ROE 61.31%
52W Range 197.39 - 421.00
Perf YTD 28.07%
Dividend Est. -
P/FCF 25.69
EPS past 5Y 35.06%
ROI 38.67%
52W High -6.75%
Beta 1.41
Dividend TTM -
Quick Ratio 0.78
Sales past 5Y 22.02%
Gross Margin 26.60%
52W Low 98.88%
ATR (14) 13.83
Dividend Ex-Date -
Current Ratio 0.78
EPS Y/Y TTM 24.12%
Oper. Margin 18.07%
RSI (14) 50.12
Volatility 2.92% 3.69%
Employees 5900
Debt/Eq 0.24
Sales Y/Y TTM 25.57%
Profit Margin 15.91%
Recom 2.12
Target Price 447.05
Option/Short Yes / Yes
LT Debt/Eq 0.20
EPS Q/Q 41.45%
Payout 0.00%
Rel Volume 0.47
Prev Close 391.07
Sales Surprise -0.26%
EPS Surprise 29.79%
Sales Q/Q 17.73%
Earnings Apr 22 AMC
Avg Volume 285.72K
Price 392.57
SMA20 -0.04%
SMA50 -1.38%
SMA200 27.98%
Trades
Volume 133,306
Change 0.38%
Date
Action
Analyst
Rating Change
Price Target Change
Apr-23-24 Upgrade
Jefferies
Hold → Buy
$340 → $450
Mar-18-24 Initiated
Deutsche Bank
Hold
$395
Feb-15-24 Upgrade
UBS
Neutral → Buy
$282 → $452
Oct-24-23 Upgrade
Robert W. Baird
Neutral → Outperform
$270 → $289
May-08-23 Upgrade
Guggenheim
Neutral → Buy
$252
Oct-27-22 Upgrade
UBS
Sell → Neutral
$142 → $238
Sep-07-22 Initiated
UBS
Sell
$142
May-24-22 Initiated
Guggenheim
Neutral
Aug-05-21 Resumed
Credit Suisse
Outperform
$205
Oct-02-20 Upgrade
Truist
Hold → Buy
$124 → $135
Jun-08-20 Upgrade
Robert W. Baird
Underperform → Neutral
$83
May-13-20 Downgrade
Wolfe Research
Outperform → Peer Perform
Apr-30-20 Upgrade
SunTrust
Sell → Hold
$85
Apr-20-20 Downgrade
Robert W. Baird
Neutral → Underperform
$77
Mar-17-20 Downgrade
SunTrust
Hold → Sell
Jan-27-20 Downgrade
SunTrust
Buy → Hold
$85 → $87
Oct-31-18 Upgrade
SunTrust
Hold → Buy
Sep-17-18 Initiated
SunTrust
Hold
$63
Jul-31-18 Upgrade
William Blair
Mkt Perform → Outperform
Nov-01-17 Downgrade
William Blair
Outperform → Mkt Perform
Show Previous Ratings
May-03-24 04:13PM
09:30AM
May-01-24 04:59PM
Apr-25-24 06:37PM
12:45PM
10:37AM
Loading…
Apr-24-24 10:37AM
09:58AM
03:08AM
Apr-23-24 10:35PM
(Thomson Reuters StreetEvents) +8.21%
Apr-22-24 05:31PM
05:25PM
04:47PM
04:24PM
(Associated Press Finance)
04:15PM
Apr-15-24 10:00AM
09:43AM
Loading…
Apr-10-24 09:43AM
Apr-08-24 04:45PM
Apr-05-24 12:10PM
04:33AM
Apr-01-24 07:16AM
(Investor's Business Daily)
Mar-28-24 04:05PM
Mar-23-24 09:00AM
(The Wall Street Journal)
Mar-22-24 09:20AM
Mar-19-24 10:48AM
Mar-18-24 08:27AM
Mar-08-24 05:00PM
Mar-04-24 12:45PM
12:00PM
Feb-29-24 03:14AM
Feb-21-24 09:13AM
09:38AM
Loading…
Feb-17-24 09:38AM
Feb-15-24 10:38AM
08:41AM
Feb-14-24 05:06PM
(Morningstar Research) +7.06%
Feb-13-24 10:24PM
(Thomson Reuters StreetEvents) +12.30%
06:53PM
Feb-12-24 04:43PM
(Associated Press Finance)
04:34PM
04:15PM
Jan-18-24 04:05AM
Jan-12-24 09:37AM
Jan-03-24 04:05PM
Dec-26-23 06:56PM
Dec-15-23 09:15AM
Dec-13-23 12:04PM
Nov-03-23 06:48PM
Oct-27-23 06:45PM
Oct-25-23 02:14PM
(Morningstar Research) -5.05%
11:51AM
Oct-24-23 10:25PM
(Thomson Reuters StreetEvents) +19.67%
06:36PM
04:09PM
(Investor's Business Daily)
11:40AM
09:51AM
07:09AM
Oct-23-23 05:48PM
04:33PM
(Associated Press Finance)
04:15PM
Sep-28-23 09:37AM
Sep-26-23 04:05PM
Sep-21-23 06:40PM
(Morningstar Research) -5.45%
Sep-19-23 12:36PM
Sep-01-23 09:15AM
Aug-30-23 06:54AM
Aug-29-23 07:47AM
Aug-23-23 08:30AM
Jul-26-23 09:54AM
Jul-25-23 10:55PM
(Thomson Reuters StreetEvents)
06:51PM
Jul-24-23 04:36PM
04:15PM
Jul-05-23 04:05PM
Jun-21-23 08:00PM
Jun-16-23 05:00AM
(American City Business Journals)
May-18-23 02:16PM
May-06-23 08:00AM
May-04-23 11:34AM
May-02-23 12:10AM
Apr-29-23 07:00AM
Apr-26-23 08:00PM
Apr-25-23 11:07PM
(Thomson Reuters StreetEvents) +11.22%
04:01PM
(Investor's Business Daily)
Apr-24-23 04:46PM
04:15PM
Apr-20-23 10:07AM
Mar-28-23 04:05PM
Mar-22-23 01:41PM
Mar-21-23 06:42AM
Mar-01-23 06:34AM
Feb-26-23 08:04AM
Feb-15-23 03:36PM
05:27AM
Feb-13-23 04:56PM
Feb-10-23 12:02AM
Jan-25-23 03:54AM
(American City Business Journals)
Jan-20-23 08:20AM
(Investor's Business Daily)
Jan-19-23 09:57PM
(Investor's Business Daily)
06:10PM
(Investor's Business Daily)
Jan-14-23 09:47AM
08:23AM
Medpace Holdings, Inc. engages in the provision of outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Its services include medical department, clinical trial management, data-driven feasibility, study-start-up, clinical monitoring, regulatory affairs, patient recruitment and retention, medical writing, biometrics and data sciences, pharmacovigilance, core laboratory, laboratories, clinics, and quality assurance. The company was founded by August James Troendle in 1992 and is headquartered in Cincinnati, OH.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Troendle August J. CEO May 02 '24 Sale 400.44 3,396 1,359,894 773,383 May 03 04:07 PM Troendle August J. CEO May 01 '24 Sale 401.56 12,934 5,193,777 776,779 May 03 04:07 PM Troendle August J. CEO Apr 30 '24 Sale 400.31 1,828 731,767 789,713 May 01 04:22 PM Troendle August J. CEO Apr 29 '24 Sale 400.69 15,102 6,051,220 791,541 May 01 04:22 PM BURWIG SUSAN E Exec. VP, Operations Mar 15 '24 Sale 403.00 102 41,106 15,181 Mar 19 05:11 PM Keating Ashley M. Director Mar 14 '24 Option Exercise 84.36 500 42,180 500 Mar 18 05:10 PM Keating Ashley M. Director Mar 14 '24 Sale 409.87 250 102,468 250 Mar 18 05:10 PM Medpace Investors, LLC 10% Owner Mar 08 '24 Sale 408.71 25,000 10,217,750 4,733,019 Mar 08 05:02 PM Troendle August J. CEO Mar 08 '24 Sale 408.71 25,000 10,217,750 4,733,019 Mar 08 05:08 PM Keating Ashley M. Director Mar 07 '24 Option Exercise 54.99 472 25,955 472 Mar 08 04:12 PM Troendle August J. CEO Mar 07 '24 Sale 410.74 75,000 30,805,500 4,758,019 Mar 08 05:08 PM Medpace Investors, LLC 10% Owner Mar 07 '24 Sale 410.74 75,000 30,805,500 4,758,019 Mar 08 05:02 PM Keating Ashley M. Director Mar 07 '24 Sale 415.00 472 195,880 0 Mar 08 04:12 PM Troendle August J. CEO Mar 06 '24 Sale 412.98 100,000 41,298,000 4,833,019 Mar 08 05:08 PM Medpace Investors, LLC 10% Owner Mar 06 '24 Sale 412.98 100,000 41,298,000 4,833,019 Mar 08 05:02 PM GEIGER JESSE J President Mar 05 '24 Option Exercise 90.65 17,679 1,602,601 21,503 Mar 06 04:42 PM Medpace Investors, LLC 10% Owner Mar 05 '24 Sale 402.70 50,000 20,135,000 4,933,019 Mar 06 04:28 PM Troendle August J. CEO Mar 05 '24 Sale 402.70 50,000 20,135,000 4,933,019 Mar 06 04:36 PM GEIGER JESSE J President Mar 04 '24 Option Exercise 90.65 22,321 2,023,399 26,145 Mar 06 04:42 PM Medpace Investors, LLC 10% Owner Mar 04 '24 Sale 403.12 50,000 20,156,000 4,983,019 Mar 06 04:28 PM Troendle August J. CEO Mar 04 '24 Sale 403.12 50,000 20,156,000 4,983,019 Mar 06 04:36 PM GEIGER JESSE J President Mar 04 '24 Sale 403.03 22,321 8,996,033 3,824 Mar 06 04:42 PM Troendle August J. CEO Mar 01 '24 Sale 401.88 80,000 32,150,400 5,033,019 Mar 04 04:15 PM Medpace Investors, LLC 10% Owner Mar 01 '24 Sale 401.88 80,000 32,150,400 5,033,019 Mar 04 04:38 PM EWALD STEPHEN P General Counsel & Corp. Secy. Mar 01 '24 Sale 400.79 350 140,276 13,341 Mar 01 04:32 PM Troendle August J. CEO Feb 29 '24 Sale 393.71 20,000 7,874,200 5,113,019 Mar 04 04:15 PM Medpace Investors, LLC 10% Owner Feb 29 '24 Sale 393.71 20,000 7,874,200 5,113,019 Mar 04 04:38 PM GEIGER JESSE J President Feb 29 '24 Sale 393.50 2,558 1,006,586 3,824 Mar 01 04:25 PM EWALD STEPHEN P General Counsel & Corp. Secy. Feb 29 '24 Sale 393.50 1,163 457,646 13,691 Mar 01 04:32 PM Keating Ashley M. Director Feb 28 '24 Option Exercise 54.99 500 27,495 500 Mar 01 04:17 PM Troendle August J. CEO Feb 28 '24 Sale 404.13 50,000 20,206,500 5,133,019 Feb 29 04:16 PM Medpace Investors, LLC 10% Owner Feb 28 '24 Sale 404.13 50,000 20,206,500 5,133,019 Feb 29 04:11 PM Keating Ashley M. Director Feb 28 '24 Sale 405.00 500 202,500 0 Mar 01 04:17 PM Troendle August J. CEO Feb 27 '24 Sale 401.88 50,000 20,094,000 5,183,019 Feb 29 04:16 PM Medpace Investors, LLC 10% Owner Feb 27 '24 Sale 401.88 50,000 20,094,000 5,183,019 Feb 29 04:11 PM Troendle August J. CEO Feb 26 '24 Sale 402.38 56,928 22,906,689 5,233,019 Feb 27 04:17 PM Medpace Investors, LLC 10% Owner Feb 26 '24 Sale 402.38 56,928 22,906,689 5,233,019 Feb 27 04:09 PM Medpace Investors, LLC 10% Owner Feb 23 '24 Sale 400.32 100,000 40,032,000 5,289,947 Feb 27 04:09 PM Troendle August J. CEO Feb 23 '24 Sale 400.32 100,000 40,032,000 5,289,947 Feb 27 04:17 PM Troendle August J. CEO Feb 22 '24 Sale 395.98 100,000 39,598,000 5,389,947 Feb 23 04:11 PM Medpace Investors, LLC 10% Owner Feb 22 '24 Sale 395.98 100,000 39,598,000 5,389,947 Feb 23 04:15 PM Medpace Investors, LLC 10% Owner Feb 21 '24 Sale 383.44 36,012 13,808,441 5,489,947 Feb 23 04:15 PM Troendle August J. CEO Feb 21 '24 Sale 383.44 36,012 13,808,441 5,489,947 Feb 23 04:11 PM Carley Brian T Director Feb 20 '24 Option Exercise 26.44 13,782 364,396 21,595 Feb 22 04:06 PM Troendle August J. CEO Feb 20 '24 Sale 386.39 13,988 5,404,823 5,525,959 Feb 21 04:45 PM Medpace Investors, LLC 10% Owner Feb 20 '24 Sale 386.39 13,988 5,404,823 5,525,959 Feb 21 04:50 PM Medpace Investors, LLC 10% Owner Feb 16 '24 Sale 391.75 50,000 19,587,500 5,539,947 Feb 21 04:50 PM Troendle August J. CEO Feb 16 '24 Sale 391.75 50,000 19,587,500 5,539,947 Feb 21 04:45 PM McCarthy Cornelius P. III Director Feb 08 '24 Option Exercise 57.17 4,710 269,271 5,038 Feb 12 04:06 PM BURWIG SUSAN E Exec. VP, Operations Dec 15 '23 Sale 303.00 2,009 608,727 15,283 Dec 18 05:03 PM BURWIG SUSAN E Exec. VP, Operations Dec 14 '23 Sale 304.15 10,391 3,160,423 17,292 Dec 18 05:03 PM Medpace Investors, LLC 10% Owner Dec 01 '23 Sale 273.26 24,039 6,568,897 5,589,947 Dec 01 04:25 PM Troendle August J. CEO Dec 01 '23 Sale 273.26 24,039 6,568,897 5,589,947 Dec 01 04:26 PM Troendle August J. CEO Nov 30 '23 Sale 272.18 7,871 2,142,329 5,613,986 Dec 01 04:26 PM Medpace Investors, LLC 10% Owner Nov 30 '23 Sale 272.18 7,871 2,142,329 5,613,986 Dec 01 04:25 PM Medpace Investors, LLC 10% Owner Nov 29 '23 Sale 272.66 21,257 5,795,875 5,621,857 Dec 01 04:25 PM Troendle August J. CEO Nov 29 '23 Sale 272.66 21,257 5,795,875 5,621,857 Dec 01 04:26 PM Medpace Investors, LLC 10% Owner Nov 28 '23 Sale 273.66 21,833 5,974,819 5,643,114 Nov 29 04:17 PM Troendle August J. CEO Nov 28 '23 Sale 273.66 21,833 5,974,819 5,643,114 Nov 29 04:16 PM Troendle August J. CEO Nov 27 '23 Sale 276.10 25,000 6,902,500 5,664,947 Nov 29 04:16 PM Medpace Investors, LLC 10% Owner Nov 27 '23 Sale 276.10 25,000 6,902,500 5,664,947 Nov 29 04:17 PM Medpace Investors, LLC 10% Owner Nov 22 '23 Sale 277.81 25,000 6,945,250 5,689,947 Nov 27 04:40 PM Troendle August J. CEO Nov 22 '23 Sale 277.81 25,000 6,945,250 5,689,947 Nov 27 04:42 PM Troendle August J. CEO Nov 21 '23 Sale 277.37 25,000 6,934,250 5,714,947 Nov 22 04:15 PM Medpace Investors, LLC 10% Owner Nov 21 '23 Sale 277.37 25,000 6,934,250 5,714,947 Nov 22 04:16 PM Troendle August J. CEO Nov 20 '23 Sale 275.45 50,000 13,772,500 5,739,947 Nov 21 04:16 PM Medpace Investors, LLC 10% Owner Nov 20 '23 Sale 275.45 50,000 13,772,500 5,739,947 Nov 21 04:17 PM Medpace Investors, LLC 10% Owner Nov 17 '23 Sale 273.91 50,000 13,695,500 5,789,947 Nov 21 04:17 PM Troendle August J. CEO Nov 17 '23 Sale 273.91 50,000 13,695,500 5,789,947 Nov 21 04:16 PM Medpace Investors, LLC 10% Owner Nov 16 '23 Sale 281.61 17,000 4,787,370 5,839,947 Nov 16 04:42 PM Troendle August J. CEO Nov 16 '23 Sale 281.61 17,000 4,787,370 5,839,947 Nov 16 04:43 PM Troendle August J. CEO Nov 15 '23 Sale 283.42 33,000 9,352,860 5,856,947 Nov 16 04:43 PM Medpace Investors, LLC 10% Owner Nov 15 '23 Sale 283.42 33,000 9,352,860 5,856,947 Nov 16 04:42 PM Medpace Investors, LLC 10% Owner Nov 14 '23 Sale 283.11 25,000 7,077,750 5,889,947 Nov 16 04:42 PM Troendle August J. CEO Nov 14 '23 Sale 283.11 25,000 7,077,750 5,889,947 Nov 16 04:43 PM BURWIG SUSAN E Exec. VP, Operations Oct 23 '23 Option Exercise 32.05 7,500 240,375 27,683 Oct 25 04:45 PM Troendle August J. CEO Sep 21 '23 Sale 244.27 61,655 15,060,467 5,914,947 Sep 21 09:41 PM Medpace Investors, LLC 10% Owner Sep 21 '23 Sale 244.27 61,655 15,060,467 5,914,947 Sep 21 09:40 PM Medpace Investors, LLC 10% Owner Sep 20 '23 Sale 255.48 65,653 16,773,028 5,976,602 Sep 21 09:40 PM Troendle August J. CEO Sep 20 '23 Sale 255.48 65,653 16,773,028 5,976,602 Sep 21 09:41 PM Troendle August J. CEO Sep 19 '23 Sale 259.66 137,379 35,671,831 6,042,255 Sep 20 04:15 PM Medpace Investors, LLC 10% Owner Sep 19 '23 Sale 259.66 137,379 35,671,831 6,042,255 Sep 20 04:16 PM Medpace Investors, LLC 10% Owner Sep 18 '23 Sale 274.76 53,385 14,668,063 6,179,634 Sep 20 04:16 PM Troendle August J. CEO Sep 18 '23 Sale 274.76 53,385 14,668,063 6,179,634 Sep 20 04:15 PM Kraft Robert O. Director Aug 14 '23 Option Exercise 26.44 13,782 364,396 13,970 Aug 16 04:15 PM Kraft Robert O. Director Aug 14 '23 Sale 265.67 13,782 3,661,464 188 Aug 16 04:15 PM Brady Kevin M. CFO & Treasurer Jul 31 '23 Option Exercise 90.65 10,000 906,500 13,000 Aug 02 04:15 PM Brady Kevin M. CFO & Treasurer Jul 31 '23 Sale 255.00 7,000 1,785,000 6,000 Aug 02 04:15 PM EWALD STEPHEN P General Counsel & Corp. Secy. Jul 27 '23 Option Exercise 107.93 21,850 2,358,270 36,704 Jul 31 04:41 PM EWALD STEPHEN P General Counsel & Corp. Secy. Jul 27 '23 Sale 254.39 21,850 5,558,422 14,854 Jul 31 04:41 PM Carley Brian T Director Jun 15 '23 Option Exercise 23.00 7,400 170,200 7,504 Jun 20 04:15 PM Medpace Investors, LLC 10% Owner Jun 08 '23 Sale 220.85 49,347 10,898,285 6,233,019 Jun 12 04:30 PM Troendle August J. CEO Jun 08 '23 Sale 220.85 49,347 10,898,285 6,233,019 Jun 12 04:32 PM Troendle August J. CEO Jun 07 '23 Sale 223.05 110,324 24,607,768 6,282,366 Jun 08 04:16 PM Medpace Investors, LLC 10% Owner Jun 07 '23 Sale 223.05 110,324 24,607,768 6,282,366 Jun 08 04:15 PM Medpace Investors, LLC 10% Owner Jun 06 '23 Sale 220.46 58,681 12,936,813 6,392,690 Jun 08 04:15 PM Troendle August J. CEO Jun 06 '23 Sale 220.46 58,681 12,936,813 6,392,690 Jun 08 04:16 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite